ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
5 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
1.4K
|
377K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
19 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
1.4K
|
377K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
AGM week - Caption this
|
|
ThriftyClown
|
26 |
5.2K |
8 |
06/11/22 |
06/11/22 |
ASX - By Stock
|
26
|
5.2K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem webinar presentation
|
|
ThriftyClown
|
32 |
7.4K |
11 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
32
|
7.4K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
ThriftyClown
|
41 |
9.6K |
13 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
41
|
9.6K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
2022 Moving Toward 2023
|
|
ThriftyClown
|
92 |
20K |
17 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
92
|
20K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
2022 Moving Toward 2023
|
|
ThriftyClown
|
92 |
20K |
16 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
92
|
20K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
TOP 442 SHAREHOLDERS AS AT 31 AUGUST 2022WITH VARIATIONS
|
|
ThriftyClown
|
30 |
7.6K |
3 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
30
|
7.6K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
TOP 442 SHAREHOLDERS AS AT 31 AUGUST 2022WITH VARIATIONS
|
|
ThriftyClown
|
30 |
7.6K |
6 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
30
|
7.6K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
TOP 442 SHAREHOLDERS AS AT 31 AUGUST 2022WITH VARIATIONS
|
|
ThriftyClown
|
30 |
7.6K |
1 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
30
|
7.6K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
TOP 442 SHAREHOLDERS AS AT 31 AUGUST 2022WITH VARIATIONS
|
|
ThriftyClown
|
30 |
7.6K |
3 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
30
|
7.6K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on PharmAust Canine Cancer Trials
|
|
ThriftyClown
|
216 |
48K |
12 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
216
|
48K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
4 |
06/08/22 |
06/08/22 |
ASX - By Stock
|
1.4K
|
377K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
10 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
1.4K
|
377K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 Option Holders as at 31 October 2022 with variations
|
|
ThriftyClown
|
5 |
1.6K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
5
|
1.6K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 Option Holders as at 31 October 2022 with variations
|
|
ThriftyClown
|
5 |
1.6K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
5
|
1.6K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 Shareholders as at 31 October 2022 with variations
|
|
ThriftyClown
|
9 |
2.5K |
8 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
9
|
2.5K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
11 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
1.4K
|
377K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
12 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
1.4K
|
377K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
8 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
1.4K
|
377K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
5 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
1.4K
|
377K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
18 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
1.4K
|
377K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Epichem awarded national grant to decarbonise plastics recycling
|
|
ThriftyClown
|
50 |
13K |
13 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
50
|
13K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Epichem awarded national grant to decarbonise plastics recycling
|
|
ThriftyClown
|
50 |
13K |
16 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
50
|
13K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notification of cessation of securities - PAA
|
|
ThriftyClown
|
93 |
23K |
18 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
93
|
23K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Science Week Conference Presentation
|
|
ThriftyClown
|
24 |
6.0K |
11 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
24
|
6.0K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Science Week Conference Presentation
|
|
ThriftyClown
|
24 |
6.0K |
25 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
24
|
6.0K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
20 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
1.4K
|
377K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
MND Phase 1/2/3 Trial review what to expect. The Chemistry !
|
|
ThriftyClown
|
14 |
3.8K |
13 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
14
|
3.8K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust ready to trial monepantel on humans to fight motor neurone disease
|
|
ThriftyClown
|
29 |
7.6K |
7 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
29
|
7.6K
|
7
|
|
ASX - By Stock
|
PAA |
Clinical Trials Interview June 2022
|
|
ThriftyClown
|
16 |
4.3K |
20 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
16
|
4.3K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL tablets arrive in Melbourne for MND Clinical Trial
|
|
ThriftyClown
|
46 |
9.8K |
11 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
46
|
9.8K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Expands Lymphoma Canine Trial to the USA
|
|
ThriftyClown
|
65 |
15K |
15 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
65
|
15K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
12 |
30/04/22 |
30/04/22 |
ASX - By Stock
|
1.4K
|
377K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
ThriftyClown
|
273 |
68K |
5 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
273
|
68K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
ThriftyClown
|
273 |
68K |
12 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
273
|
68K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Trial Time , MND , SARs / Covid
|
|
ThriftyClown
|
47 |
10K |
17 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
47
|
10K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA appoints trial manager & receives $200k from FightMND
|
|
ThriftyClown
|
21 |
5.4K |
20 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
21
|
5.4K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
4 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
1.4K
|
377K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
6 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
1.4K
|
377K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
14 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
1.4K
|
377K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Human Trialing Commencement in 60 Days
|
|
ThriftyClown
|
35 |
7.1K |
10 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
35
|
7.1K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Preliminary MPL antiviral leukaemia preclinical WEHI results
|
|
ThriftyClown
|
86 |
17K |
13 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
86
|
17K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Key Appointment to Progress MPL COVID-19 Clinical Trial
|
|
ThriftyClown
|
167 |
38K |
18 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
167
|
38K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem Confirms Effectiveness of OHD E-Waste Project
|
|
ThriftyClown
|
50 |
9.0K |
9 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
50
|
9.0K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
ThriftyClown
|
60 |
13K |
9 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
60
|
13K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
ThriftyClown
|
60 |
13K |
23 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
60
|
13K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on Manufacture of MPL & Tablets for Clinical Trials
|
|
ThriftyClown
|
16 |
4.2K |
12 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
16
|
4.2K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ThriftyClown
|
1.4K |
377K |
15 |
15/01/22 |
15/01/22 |
ASX - By Stock
|
1.4K
|
377K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 Option Holders as at 29/11/2021
|
|
ThriftyClown
|
15 |
4.9K |
24 |
28/12/21 |
28/12/21 |
ASX - By Stock
|
15
|
4.9K
|
24
|
|